Quality of RCTs exploring Helicobacter pylori eradication for the prevention of gastric cancer and preneoplastic lesions

References

• Correa P. Human gastric carcinogenesis: a multistep and multifactorial process – First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res.52, 6735–6740 (1992).
   PubMed Web of Science ®Google Scholar
• Kunz R, Vist G, Oxman AD. Randomisation to protect against selection bias in healthcare trials. Cochrane Database Syst. Rev.2, MR000012 (2007).
   Google Scholar
• Moher D, Pham B, Jones A et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet352, 609–613 (1998).
   PubMed Web of Science ®Google Scholar
• Moher D, Jones A, Lepage L; for the CONSORT Group. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. JAMA285, 1992–1995 (2001).
   PubMed Web of Science ®Google Scholar
• Moher D, Schulz KF, Altman DG; for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet357, 1191–1194 (2001).
   PubMed Web of Science ®Google Scholar
• Ogura K, Hirata Y, Yanai A et al. The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer. J. Clin. Gastroenterol.42, 279–283 (2008).
   PubMed Web of Science ®Google Scholar
• Fuccio L, Zagari RM, Minardi ME et al. Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer. Aliment Pharmacol. Ther.25, 133–141 (2007).
   PubMed Web of Science ®Google Scholar
• Ito M, Takata S, Tatsugami M et al. Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review. J. Gastroenterol.44, 365–371 (2009).
   PubMed Web of Science ®Google Scholar
• Ito M. Helicobacter pylori eradication for gastric cancer prevention. Expert Rev. Anticancer Ther.10(1), 1–3 (2010).
   PubMed Web of Science ®Google Scholar
• Murakami K, Kodama M, Sato R et al.Helicobacter pylori eradication and associated changes in the gastric mucosa. Expert Rev. Anti. Infect. Ther.3(5), 757–764 (2005).
   PubMedGoogle Scholar
• Jüni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ323, 42–46 (2001).
   PubMed Web of Science ®Google Scholar
• Schulz KF, Altman DG, Moher D; for the CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ340, c332 (2010).
   PubMed Web of Science ®Google Scholar
• Rennie D. CONSORT revised – improving the reporting of randomized trials. JAMA285(15), 2006–2007 (2001).
   PubMed Web of Science ®Google Scholar
• Fuccio L, Zagari RM, Eusebi LH et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann. Intern. Med.151(2), 121–128 (2009).
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2. Wiley-Blackwell, NJ, USA (2009).
   Google Scholar
• Moher D, Hopewell S, Schulz KF et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ340, c869 (2010).
   PubMed Web of Science ®Google Scholar
• Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann. Intern. Med.134, 657–662 (2001).
   PubMed Web of Science ®Google Scholar
• Zhou L, Sung JJ, Lin S et al. A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication. Chin. Med. J. (Engl.)116(1), 11–14 (2003).
   PubMed Web of Science ®Google Scholar
• Ley C, Mohar A, Guarner J et al.Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial. Cancer Epidemiol. Biomarkers Prev.13(1), 4–10 (2004).
   PubMed Web of Science ®Google Scholar
• Wong BC, Lam SK, Wong WM et al.Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA291(2), 187–194 (2004).
   PubMed Web of Science ®Google Scholar
• Sung JJ, Lin SR, Ching JY et al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology119(1), 7–14 (2000).
   PubMed Web of Science ®Google Scholar
• Gail MH, You WC, Chang YS et al. Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Shandong, China: design issues and initial data. Control Clin. Trials19(4), 352–369 (1998).
   PubMedGoogle Scholar
• Schenk BE, Kuipers EJ, Nelis GF et al. Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy. Gut46(5), 615–621 (2000).
   PubMed Web of Science ®Google Scholar
• Kuipers EJ, Nelis GF, Klinkenberg-Knol EC et al. Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. Gut53(1), 12–20 (2004).
   PubMed Web of Science ®Google Scholar
• Yang HB, Sheu BS, Wang ST et al.H. pylori eradication prevents the progression of gastric intestinal metaplasia in reflux esophagitis patients using long-term esomeprazole. Am. J. Gastroenterol.104(7), 1642–1649 (2009).
   PubMed Web of Science ®Google Scholar
• Witteman EM, Mravunac M, Becx MJ et al. Improvement of gastric inflammation and resolution of epithelial damage one year after eradication of Helicobacter pylori. J. Clin. Pathol.48(3), 250–256 (1995).
   PubMed Web of Science ®Google Scholar
• Ruiz B, Garay J, Correa P et al. Morphometric evaluation of gastric antral atrophy: improvement after cure of Helicobacter pylori infection. Am. J. Gastroenterol.96(12), 3281–3287 (2001).
   PubMed Web of Science ®Google Scholar
• Kamada T, Haruma K, Hata J et al. The long-term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis. Aliment. Pharmacol. Ther.18(2), 245–252 (2003).
   PubMed Web of Science ®Google Scholar
• Lu B, Chen MT, Fan YH et al. Effects of Helicobacter pylori eradication on atrophic gastritis and intestinal metaplasia: a 3-year follow-up study. World J. Gastroenterol.11(41), 6518–6520 (2005).
   PubMed Web of Science ®Google Scholar
• Arkkila PE, Seppälä K, Färkkilä MA et al.Helicobacter pylori eradication in the healing of atrophic gastritis: a one-year prospective study. Scand. J. Gastroenterol.41(7), 782–790 (2006).
   PubMed Web of Science ®Google Scholar
• Miehlke S, Kirsch C, Dragosics B et al.Helicobacter pylori and gastric cancer: current status of the Austrian Czech German gastric cancer prevention trial (PRISMA Study). World J. Gastroenterol.7(2), 243–247 (2001).
   PubMed Web of Science ®Google Scholar
• Saita H, Murakami M, Takahashi Y et al. Factors influencing Helicobacter pylori eradication with 2 week combination therapy of lansoprazole and amoxycillin: intragastric distribution of colonization and gastric mucosal atrophy. J. Gastroenterol. Hepatol.13(7), 725–731 (1998).
   PubMed Web of Science ®Google Scholar
• Befrits R, Sjöstedt S, Tour R et al. Long-term effects of eradication of Helicobacter pylori on relapse and histology in gastric ulcer patients: a two-year follow-up study. Scand. J. Gastroenterol.39(11), 1066–1072 (2004).
   PubMed Web of Science ®Google Scholar
• Correa P, Fontham ET, Bravo JC et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J. Natl Cancer Inst.92(23), 1881–1888 (2000).
   PubMed Web of Science ®Google Scholar
• Miwa H, Hirai S, Nagahara A et al. Cure of Helicobacter pylori infection does not improve symptoms in non-ulcer dyspepsia patients – a double-blind placebo-controlled study. Aliment. Pharmacol. Ther.14(3), 317–324 (2000).
   PubMed Web of Science ®Google Scholar
• De Leest HT, Steen KS, Bloemena E et al.Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial. J. Clin. Gastroenterol.43(2), 140–146 (2009).
   PubMed Web of Science ®Google Scholar
• Fukase K, Kato M, Kikuchi S et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomized controlled trial. Lancet372, 392–397 (2008).
   PubMed Web of Science ®Google Scholar
• Schulz KF, Chalmers I, Hayes RJ et al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA273, 408–412 (1995).
   PubMed Web of Science ®Google Scholar
• Chalmers TC, Celano P, Sacks HS, Smith H. Bias in treatment assignment in controlled clinical trials. N. Engl. J. Med.309, 1358–1361 (1983).
   PubMed Web of Science ®Google Scholar
• Gibson CA, Kirk EP, LeCheminant JD et al. Reporting quality of randomized trials in the diet and exercise literature for weight loss. BMC Med. Res. Methodol.5(1), 9 (2005).
   PubMedGoogle Scholar
• Correa P, Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology133, 659–672 (2007).
   PubMed Web of Science ®Google Scholar
• Ito M, Tanaka S, Kamada T et al. Causal role of Helicobacter pylori infection and eradication therapy in gastric carcinogenesis. World J. Gastroenterol.12(1), 10–16 (2006).
   PubMed Web of Science ®Google Scholar
• Deeks JJ, Altman DG. Inadequate reporting of controlled trials as short reports. Lancet352(9144), 1908 (1998).
   PubMed Web of Science ®Google Scholar
• Egger M, Jüni P, Bartlett C et al. Value of flow diagrams in reports of randomized controlled trials. JAMA285(15), 1996–1999 (2001).
   PubMed Web of Science ®Google Scholar
• Soares HP, Daniels S, Kumar A et al. Bad reporting does not mean bad methods for randomised trials: observational study of randomised controlled trials performed by the Radiation Therapy Oncology Group. BMJ328, 22–24 (2004).
   PubMed Web of Science ®Google Scholar